Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Dec 09, 2024

SELL
$25.29 - $35.48 $140,410 - $196,984
-5,552 Closed
0 $0
Q3 2022

Dec 09, 2024

SELL
$24.0 - $33.42 $153,528 - $213,787
-6,397 Reduced 53.54%
5,552 $159,000
Q2 2022

Dec 09, 2024

BUY
$24.78 - $33.36 $296,096 - $398,618
11,949 New
11,949 $302,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.1B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.